Drugs / ETR028
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05572190 | Sep 2022 → Mar 2024 | — | Elysium Therapeutics, Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ETR028 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05572190 ↗ |
| Route | Oral | “single oral doses” NCT05572190 ↗ |